Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
414.40    -2.40 (-0.58%)
Bid:
412.60
Ask:
413.40
Spread: 0.80 (0.194%)
Market Cap: £2.13b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Update on LTPA amendment

28 Mar 2019 16:20

RNS Number : 3817U
QinetiQ Group plc
28 March 2019
 

Update on LTPA amendment

28 March 2019

QinetiQ Group plc ('QinetiQ' or 'the Group') today issues an update on its discussions with the UK Ministry of Defence (MOD) regarding a contract amendment to the Long Term Partnering Agreement (LTPA) covering the operation of 16 LTPA sites which were not part of the amendment signed in December 2016.

 

On 1 April 2018, QinetiQ and the MOD put in place a twelve-month interim pricing arrangement covering QinetiQ's continued delivery of test, evaluation and training support services at these 16 sites under existing LTPA contract terms.

 

QinetiQ and the MOD have made good progress during the discussions on the LTPA contract amendment and all contract terms have been agreed. The proposed contract amendment is now in the final stages of negotiation with the MOD. QinetiQ and the MOD are aiming to sign the contract amendment shortly, once these final negotiations have been completed.

 

LTPA related work continues as normal under the existing terms of the contract.

 

This announcement contains inside information and the person responsible for making this announcement is Jon Messent, Company Secretary.

 

For further information please contact:

 

 

 

David Bishop, Group Director Investor Relations and Communications:

+44 (0) 7920 108675

Ian Brown, Group Head of Investor Relations:

+44 (0) 7908 251123

Jon Hay-Campbell, Group Head of Communications:

+44 (0) 7500 856953

 

About QinetiQ:

 

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

Disclaimer

This document contains certain forward-looking statements relating to the business, strategy, financial performance and results of the Company and/or the industry in which it operates. Actual results, levels of activity, performance, achievements and events are most likely to vary materially from those implied by the forward-looking statements. The forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words 'believes',' expects', 'predicts', 'intends', 'projects', 'plans', 'estimates', 'aims', 'foresees', 'anticipates', 'targets', 'goals', 'due', 'could', 'may', 'should', 'potential', 'likely' and similar expressions, although these words are not the exclusive means of doing so. These forward-looking statements include, without limitation, statements regarding the Company's future financial position, income growth, impairment charges, business strategy, projected levels of growth in the relevant markets, projected costs, estimates of capital expenditures, and plans and objectives for future operations. Forward-looking statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Nothing in this document should be regarded as a profit forecast.

The forward-looking statements, including assumptions, opinions and views of the Company or cited from third party sources, contained in this announcement are solely opinions and forecasts which are uncertain and subject to risks. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to be correct. Actual results may differ materially from those expressed or implied by these forward-looking statements. A number of factors could cause actual events to differ significantly and these are set out in the principal risks and uncertainties section of this document. Most of these factors are difficult to predict accurately and are generally beyond the control of the Company. Any forward-looking statements made by, or on behalf of, the Company speak only as of the date they are made. Save as required by law, the Company will not publicly release the results of any revisions to any forward-looking statements in this document that may occur due to any change in the Directors' expectations or to reflect events or circumstances after the date of this document.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDCKFDDABKDPNB
Date   Source Headline
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSPre-close Trading update
21st Sep 20203:57 pmRNSDirectorate Change
10th Sep 202010:29 amRNSDirector/PDMR Shareholding
20th Aug 20202:14 pmRNSHolding(s) in Company
13th Aug 20204:47 pmRNSDirector/PDMR Shareholding
11th Aug 202011:56 amRNSDirector/PDMR Shareholding
10th Aug 202011:28 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.